The Increasing Spectrum of Indications of Whole-Body MRI beyond Oncology: Imaging Answers to Clinical Needs

Seminars in Musculoskeletal Radiology

Volumn 19, Issue 4, 2015, Pages 348-362

  Lecouvet, Frédéric E ^a   Michoux, Nicolas ^a   Toukap, Adrien Nzeusseu ^a   Larbi, Ahmed ^a   Berg, Bruno Vande ^a   Malghem, Jacques ^a   Triqueneaux, Perrine ^a   Omoumi, Patrick ^b   Stoenoiu, Maria Simona ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

biomarker; diffusion weighted MRI; inflammation; MRI; myositis; rheumatisms; spondyloarthropathy; systemic sclerosis; treatment; whole body MRI

Indexed keywords

ANKYLOSING SPONDYLITIS; CARTILAGE TUMOR; CLINICAL DECISION MAKING; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); DISEASE ACTIVITY; DISEASE SEVERITY; EOSINOPHILIC FASCIITIS; EOSINOPHILIC GRANULOMA; HUMAN; IDIOPATHIC DISEASE; IMAGING; LANGERHANS CELL HISTIOCYTOSIS; LUMBAR SPINE; MYOPATHY; MYOSITIS; NERVE LESION; NEUROMUSCULAR DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REVIEW; RHEUMATIC DISEASE; SACROILIAC JOINT; SAPHO SYNDROME; SARCOIDOSIS; SPONDYLOARTHROPATHY; SYSTEMIC SCLEROSIS; VASCULAR DISEASE; WHOLE BODY MRI; MUSCULOSKELETAL DISEASE; PATHOLOGY; PROCEDURES; WHOLE BODY IMAGING;

HUMANS; MAGNETIC RESONANCE IMAGING; MUSCULOSKELETAL DISEASES; WHOLE BODY IMAGING;

EID: 84947805351     PISSN: 10897860     EISSN: 1098898X     Source Type: Journal    
DOI: 10.1055/s-0035-1564695     Document Type: Review

References (91)

1. Johnson K. M., Leavitt G. D., Kayser H. W. Total-body MR imaging in as little as 18 seconds. Radiology: 1997; 202 1 262 267
2. Horvath L. J., Burtness B. A., McCarthy S., Johnson K. M. Total-body echo-planar MR imaging in the staging of breast cancer: comparison with conventional methods-early experience. Radiology: 1999; 211 1 119 128
3. Eustace S., Tello R., DeCarvalho V., et al. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol: 1997; 169 6 1655 1661
4. Lauenstein T. C., Goehde S. C., Herborn C. U., et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology: 2004; 233 1 139 148
5. Pasoglou V., Michoux N., Peeters F., et al. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease. Radiology: 2015; 275 1 155 166
6. Lecouvet F. E., Larbi A., Pasoglou V., et al. MRI for response assessment in metastatic bone disease. Eur Radiol: 2013; 23 7 1986 1997
7. Lecouvet F. E., Talbot J. N., Messiou C., Bourguet P., Liu Y., de Souza N. M.; EORTC Imaging Group Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group. Eur J Cancer: 2014; 50 15 2519 2531
8. Baur-Melnyk A., Buhmann S., Becker C., et al. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. AJR Am J Roentgenol: 2008; 190 4 1097 1104
9. van Ufford H. M., Kwee T. C., Beek F. J., et al. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT. AJR Am J Roentgenol: 2011; 196 3 662 669
10. Lecouvet F. E., El Mouedden J., Collette L., et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol: 2012; 62 1 68 75
11. Althoff C. E., Appel H., Rudwaleit M., et al. Whole-body MRI as a new screening tool for detecting axial and peripheral manifestations of spondyloarthritis. Ann Rheum Dis: 2007; 66 7 983 985
12. Fritz J., Tzaribatchev N., Claussen C. D., Carrino J. A., Horger M. S. Chronic recurrent multifocal osteomyelitis: comparison of whole-body MR imaging with radiography and correlation with clinical and laboratory data. Radiology: 2009; 252 3 842 851
13. Schanz S., Henes J., Ulmer A., et al. Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms. Eur Radiol: 2013; 23 1 212 221
14. Weckbach S. Whole-body MRI for inflammatory arthritis and other multifocal rheumatoid diseases. Semin Musculoskelet Radiol: 2012; 16 5 377 388
15. Castro T. C., Lederman H., Terreri M. T., Caldana W. I., Kaste S. C., Hilário M. O. The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus. Br J Radiol: 2011; 84 1003 621 628
16. Schmidt G. P., Reiser M. F., Baur-Melnyk A. Whole-body imaging of bone marrow. Semin Musculoskelet Radiol: 2009; 13 2 120 133
17. Schmidt G. P., Baur-Melnyk A., Herzog P., et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol: 2005; 40 12 743 753
18. Lecouvet F. E., Simon M., Tombal B., Jamart J., Vande Berg B. C., Simoni P. Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa). Eur Radiol: 2010; 20 12 2973 2982
19. Rennie W. J., Dhillon S. S., Conner-Spady B., Maksymowych W. P., Lambert R. G. Magnetic resonance imaging assessment of spinal inflammation in ankylosing spondylitis: standard clinical protocols may omit inflammatory lesions in thoracic vertebrae. Arthritis Rheum: 2009; 61 9 1187 1193
20. Weckbach S., Schewe S., Michaely H. J., Steffinger D., Reiser M. F., Glaser C. Whole-body MR imaging in psoriatic arthritis: additional value for therapeutic decision making. Eur J Radiol: 2011; 77 1 149 155
21. Poggenborg R. P., Eshed I., Ostergaard M., et al. Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by 'head-to-toe' whole-body MRI and clinical examination. Ann Rheum Dis: 2015; 74 5 823 829
22. Poggenborg R. P., Wiell C., Boyesen P., et al. No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial. Rheumatology (Oxford): 2014; 53 4 746 756
23. Khan M. A. Newer clinical and radiographic features of seronegative spondyloarthropathies. Curr Opin Rheumatol: 1989; 1 2 139 143
24. Althoff C. E., Sieper J., Song I. H., et al. Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI. Ann Rheum Dis: 2013; 72 6 967 973
25. Barkham N., Keen H. I., Coates L. C., et al. Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum: 2009; 60 4 946 954
26. Rudwaleit M., Schwarzlose S., Hilgert E. S., Listing J., Braun J., Sieper J. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis: 2008; 67 9 1276 1281
27. Rudwaleit M., Landewé R., van der Heijde D., et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis: 2009; 68 6 770 776
28. Rudwaleit M., van der Heijde D., Landewé R., et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis: 2009; 68 6 777 783
29. Mandl P., Navarro-Compán V., Terslev L., et al. European League Against Rheumatism (EULAR). EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis: 2015; 74 7 1327 1339
30. Aydin S. Z., Maksymowych W. P., Bennett A. N., McGonagle D., Emery P., Marzo-Ortega H. Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years. Ann Rheum Dis: 2012; 71 1 56 60
31. Hermann K. G., Baraliakos X., van der Heijde D. M., et al. Assessment in SpondyloArthritis international Society (ASAS). Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group. Ann Rheum Dis: 2012; 71 8 1278 1288
32. Landewé R. B., Hermann K. G., van der Heijde D. M., et al. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment. J Rheumatol: 2005; 32 10 2050 2055
33. Krohn M., Braum L. S., Sieper J., et al. Erosions and fatty lesions of sacroiliac joints in patients with axial spondyloarthritis: evaluation of different MRI techniques and two scoring methods. J Rheumatol: 2014; 41 3 473 480
34. Maksymowych W. P., Inman R. D., Salonen D., et al. Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis. Arthritis Rheum: 2005; 53 4 502 509
35. Maksymowych W. P., Inman R. D., Salonen D., et al. Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum: 2005; 53 5 703 709
36. Mager A. K., Althoff C. E., Sieper J., Hamm B., Hermann K. G. Role of whole-body magnetic resonance imaging in diagnosing early spondyloarthritis. Eur J Radiol: 2009; 71 2 182 188
37. Weber U., Pfirrmann C. W., Kissling R. O., Hodler J., Zanetti M. Whole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis. BMC Musculoskelet Disord: 2007; 8 20
38. Weber U., Hodler J., Kubik R. A., et al. Sensitivity and specificity of spinal inflammatory lesions assessed by whole-body magnetic resonance imaging in patients with ankylosing spondylitis or recent-onset inflammatory back pain. Arthritis Rheum: 2009; 61 7 900 908
39. Weber U., Hodler J., Jurik A. G., et al. Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: validation of whole body MRI against conventional MRI. Ann Rheum Dis: 2010; 69 4 648 653
40. Bennett A. N., Marzo-Ortega H., Rehman A., Emery P., McGonagle D.; Leeds Spondyloarthropathy Group. The evidence for whole-spine MRI in the assessment of axial spondyloarthropathy. Rheumatology (Oxford): 2010; 49 3 426 432
41. Eshed I., Bollow M., McGonagle D. G., et al. MRI of enthesitis of the appendicular skeleton in spondyloarthritis. Ann Rheum Dis: 2007; 66 12 1553 1559
42. Muche B., Bollow M., François R. J., Sieper J., Hamm B., Braun J. Anatomic structures involved in early- and late-stage sacroiliitis in spondylarthritis: a detailed analysis by contrast-enhanced magnetic resonance imaging. Arthritis Rheum: 2003; 48 5 1374 1384
43. Karpitschka M., Godau-Kellner P., Kellner H., et al. Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging. Eur Radiol: 2013; 23 7 1773 1784
44. Chary-Valckenaere I., d'Agostino M. A., Loeuille D. Role for imaging studies in ankylosing spondylitis. Joint Bone Spine: 2011; 78 2 138 143
45. Bredella M. A., Steinbach L. S., Morgan S., Ward M., Davis J. C. MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis. AJR Am J Roentgenol: 2006; 187 6 1420 1426
46. Gezmis E., Donmez F. Y., Agildere M. Diagnosis of early sacroiliitis in seronegative spondyloarthropathies by DWI and correlation of clinical and laboratory findings with ADC values. Eur J Radiol: 2013; 82 12 2316 2321
47. Bozgeyik Z., Ozgocmen S., Kocakoc E. Role of diffusion-weighted MRI in the detection of early active sacroiliitis. AJR Am J Roentgenol: 2008; 191 4 980 986
48. Weber U., Zubler V., Zhao Z., et al. Does spinal MRI add incremental diagnostic value to MRI of the sacroiliac joints alone in patients with non-radiographic axial spondyloarthritis? Ann Rheum Dis: 2015; 74 6 985 992
49. van der Heijde D., Sieper J., Maksymowych W. P., et al. Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis. Arthritis Rheum (Munch): 2014; 66 3 667 673
50. Guérin-Pfyffer S., Guillaume-Czitrom S., Tammam S., Koné-Paut I. Evaluation of chronic recurrent multifocal osteitis in children by whole-body magnetic resonance imaging. Joint Bone Spine: 2012; 79 6 616 620
51. Coates L. C., Hodgson R., Conaghan P. G., Freeston J. E. MRI and ultrasonography for diagnosis and monitoring of psoriatic arthritis. Best Pract Res Clin Rheumatol: 2012; 26 6 805 822
52. Chamot A. M., Benhamou C. L., Kahn M. F., Beraneck L., Kaplan G., Prost A. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases [in French]. Rev Rhum Mal Osteoartic: 1987; 54 3 187 196
53. Crouzet J., Claudepierre P., Aribi E. H., et al. Two cases of discitis due to Propionibacterium acnes. Rev Rhum Engl Ed: 1998; 65 1 68 71
54. Earwaker J. W., Cotten A. SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol: 2003; 32 6 311 327
55. Parlier-Cuau C., Laredo J. Vertebral involvement in SAPHO syndrome [in French]. J Radiol: 2010; 91 (9 Pt 2): 1068 1078
56. Magrey M., Khan M. A. New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome. Curr Rheumatol Rep: 2009; 11 5 329 333
57. Sundaram M., McDonald D., Engel E., Rotman M., Siegfried E. C. Chronic recurrent multifocal osteomyelitis: an evolving clinical and radiological spectrum. Skeletal Radiol: 1996; 25 4 333 336
58. Jurik A. G. Chronic recurrent multifocal osteomyelitis. Semin Musculoskelet Radiol: 2004; 8 3 243 253
59. Mammen A. L. Skeletal muscle involvement. In: Varga J., Denton C. P., Wigley F. M. eds. Scleroderma: From Pathogenesis to Comprehensive Management. London, UK Springer: 2012; 525 529
60. Avouac J., Walker U. A., Hachulla E., et al. the EUSTAR collaborators the EUSTAR collaborators. Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis: 2014
61. West S. G., Killian P. J., Lawless O. J. Association of myositis and myocarditis in progressive systemic sclerosis. Arthritis Rheum: 1981; 24 5 662 668
62. Abdel-Magied R. A., Lotfi A., AbdelGawad E. A. Magnetic resonance imaging versus musculoskeletal ultrasonography in detecting inflammatory arthropathy in systemic sclerosis patients with hand arthralgia. Rheumatol Int: 2013; 33 8 1961 1966
63. Akbayrak E., Dinser R., Müller-Ladner U., Tarner I. H. Low-field magnetic resonance imaging study on carpal arthritis in systemic sclerosis-low-grade erosive arthritis of carpal bones is an unexpected and frequent disease manifestation. Arthritis Res Ther: 2013; 15 1 R2
64. Schanz S., Henes J., Ulmer A., et al. Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach. AJR Am J Roentgenol: 2013; 200 4 W376 W382
65. Ranque B., Authier F. J., Le-Guern V., et al. A descriptive and prognostic study of systemic sclerosis-associated myopathies. Ann Rheum Dis: 2009; 68 9 1474 1477
66. Bohan A., Peter J. B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med: 1975; 292 7 344 347
67. Bohan A., Peter J. B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med: 1975; 292 8 403 407
68. Shelly M. J., Bolster F., Foran P., Crosbie I., Kavanagh E. C., Eustace S. J. Whole-body magnetic resonance imaging in skeletal muscle disease. Semin Musculoskelet Radiol: 2010; 14 1 47 56
69. Farber J. M., Buckwalter K. A. MR imaging in nonneoplastic muscle disorders of the lower extremity. Radiol Clin North Am: 2002; 40 5 1013 1031
70. Yoshida K., Kurosaka D., Joh K., et al. Fasciitis as a common lesion of dermatomyositis, demonstrated early after disease onset by en bloc biopsy combined with magnetic resonance imaging. Arthritis Rheum: 2010; 62 12 3751 3759
71. Cantwell C., Ryan M., O'Connell M., et al. A comparison of inflammatory myopathies at whole-body turbo STIR MRI. Clin Radiol: 2005; 60 2 261 267
72. Walker U. A. Imaging tools for the clinical assessment of idiopathic inflammatory myositis. Curr Opin Rheumatol: 2008; 20 6 656 661
73. Del Grande F., Carrino J. A., Del Grande M., Mammen A. L., Christopher Stine L. Magnetic resonance imaging of inflammatory myopathies. Top Magn Reson Imaging: 2011; 22 2 39 43
74. Mercuri E., Pichiecchio A., Allsop J., Messina S., Pane M., Muntoni F. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging: 2007; 25 2 433 440
75. Brennan D. D., Whelan P. F., Robinson K., et al. Rapid automated measurement of body fat distribution from whole-body MRI. AJR Am J Roentgenol: 2005; 185 2 418 423
76. Shulman L. E. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians: 1975; 88 70 86
77. Kirchgesner T., Dallaudière B., Omoumi P., et al. Eosinophilic fasciitis: typical abnormalities, variants and differential diagnosis of fasciae abnormalities using MR imaging. Diagn Interv Imaging: 2015; 96 4 341 348
78. Baumann F., Brühlmann P., Andreisek G., Michel B. A., Marincek B., Weishaupt D. MRI for diagnosis and monitoring of patients with eosinophilic fasciitis. AJR Am J Roentgenol: 2005; 184 1 169 174
79. Moulton S. J., Kransdorf M. J., Ginsburg W. W., Abril A., Persellin S. Eosinophilic fasciitis: spectrum of MRI findings. AJR Am J Roentgenol: 2005; 184 3 975 978
80. Sekine T., Amano Y., Hidaka F., et al. Hepatosplenic and muscular sarcoidosis: characterization with MR imaging. Magn Reson Med Sci: 2012; 11 2 83 89
81. Wieërs G., Lhommel R., Lecouvet F., Van den Bergh P., Lambert M. A tiger man. Lancet: 2012; 380 9856 1859
82. Mangino D., Stover D. E. Sarcoidosis presenting as metastatic bony disease. A case report and review of the literature on vertebral body sarcoidosis. Respiration: 2004; 71 3 292 294
83. Kuzyshyn H., Feinstein D., Kolasinski S. L., Eid H. Osseous sarcoidosis: a case series. Rheumatol Int: 2015; 35 5 925 933
84. Atkin K. L., Ditchfield M. R. The role of whole-body MRI in pediatric oncology. J Pediatr Hematol Oncol: 2014; 36 5 342 352
85. Dallaudière B., Kerger J., Malghem J., Galant C., Lecouvet F. E. Adult onset asynchronous multifocal eosinophilic granuloma of bone: an 11-year follow-up. Acta Radiol Open: 2015; 4 2 2047981614552217
86. Mueller W. P., Melzer H. I., Schmid I., Coppenrath E., Bartenstein P., Pfluger T. The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis. Eur J Nucl Med Mol Imaging: 2013; 40 3 356 363
87. Miettunen P. M., Lafay-Cousin L., Guilcher G. M., Nettel-Aguirre A., Moorjani V. Widespread osteonecrosis in children with leukemia revealed by whole-body MRI. Clin Orthop Relat Res: 2012; 470 12 3587 3595
88. Schmidt G. P., Reiser M. F., Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skeletal Radiol: 2007; 36 12 1109 1119
89. Nguyen R., Jett K., Harris G. J., Cai W., Friedman J. M., Mautner V. F. Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1. J Neurooncol: 2014; 116 2 307 313
90. Van Meerbeeck S. F., Verstraete K. L., Janssens S., Mortier G. Whole body MR imaging in neurofibromatosis type 1. Eur J Radiol: 2009; 69 2 236 242
91. Teixeira S. R., Elias Junior J., Nogueira-Barbosa M. H., Guimarães M. D., Marchiori E., Santos M. K. Whole-body magnetic resonance imaging in children: state of the art. Radiol Bras: 2015; 48 2 111 120